Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

TCP Reliable Announces the Acquisition of Isneaufroid

TCP Reliable, dedicated to ensure product integrity for the lifescience industry, recently completed a business acquisition with Isneaufroid, a manufacturer of temperature controlled packaging products located in Maromme, France.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The Isneaufroid products will be marketed under the Cryopak brand, a subsidiary of TCP Reliable.

"The acquisition with Isneaufroid is a step towards our mission to expand the presence of Cryopak within the European market," Bill Hingle, Marketing Director for TCP Reliable, said.

In addition, Isneaufroid offers cold storage services to pre-condition components as well as provides longer term storage and delivery services. "The acquisition of Isneaufroid brings additional manufacturing capacity of reusable gel pack bottles to the European market and provides Cryopak with a new service capability," Hingle said. "This capability provides clients with truly global solutions that are consistent and cost effective."
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?